JG
FDMT icon

Jain Global’s 4D Molecular Therapeutics FDMT Stock Holding History

Jain Global’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
+23,537
New +$229K ﹤0.01% 1371
2026
Q1 		– Sell
-40,464
Closed -$303K – 1348
2025
Q4 		$303K Buy
+40,464
New +$410K ﹤0.01% 951
2025
Q2 		– Sell
-21,707
Closed -$70.1K – 1324
2025
Q1 		$70.1K Sell
21,707
-31,879
-59% -$150K ﹤0.01% 993
2024
Q4 		$298K Buy
+53,586
New +$421K 0.01% 558

Other funds holding FDMT

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Jain Global's FDMT Position: Q2 2026 in Review

Jain Global opened a new position in 4D Molecular Therapeutics (FDMT) in Q2 2026: 23,537 shares worth $313K. The stake represents ﹤0.01% of the portfolio and ranks #1371 among its holdings. This is a return to the name: Jain Global previously reported a position in FDMT as recently as Q4 2025.

Jain Global first reported a position in FDMT in Q4 2024 and has held it in 4 quarters since. 158 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • Jain Global held 23,537 shares of 4D Molecular Therapeutics worth $313K as of Q2 2026.
  • 4D Molecular Therapeutics was a new Jain Global position in Q2 2026.
  • 4D Molecular Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1371 holding.
  • Jain Global first reported a position in 4D Molecular Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 158 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.